Rapid Fire Round with Nilab Haydare: Life at ImmuONE
Q: What attracted you to ImmuONE as a company? A: I was initially drawn to ImmuONE because of my positive experience during my final…
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse quis nibh eget urna placerat dictum in ac mauris. Etiam pellentesque tristique pretium.
Q: What attracted you to ImmuONE as a company? A: I was initially drawn to ImmuONE because of my positive experience during my final…
Q: What attracted you to ImmuONE as a company? A: I was initially drawn to ImmuONE because of my positive experience during my final…
The goal in every lab is to ‘work smarter, not harder.’ This is especially true in pharmacological labs, where there is an ever-greater focus..
ImmuONE today announced the launch of ImmuPHAGE™, an in vitro assay that can evaluate how substances interact with the macrophage white blood cells found…
Foetal bovine serum (FBS) is widely used in cell culture media, but may limit the human relevance of safety assessments. A new study demonstrates…
Nilab Haydare is a pre-clinical scientist at ImmuONE specialising in in-vitro toxicology research. She will be presenting the poster of her study,…
Despite the increasing power of non-animal approaches, the move towards their inclusion in pharmaceutical safety testing is slow, largely due to a lack of…
New research demonstrates how an analytical technique known as morphometric phenotyping can distinguish between the effects of different nicotine products on immune cells.
Lung macrophages play a significant role in the chronic inflammation associated with cystic fibrosis